Type
. CD1-restricted T cell recognition of microbial lipoglycan antigens. Science (New York, N.Y.). 1995;269(5221):227-30.
Type
. Leprosy. The beginning of an end to a public health problem?. Dermatologic clinics. 1995;13(3):525-36.
Type
. [Assessment of the Mitsuda reaction in lepromatous patients inactive before and after immunotherapy]. Revista da Sociedade Brasileira de Medicina Tropical. 1995;28(3):233-6.
Type
. Treatment of leprosy with WHO's standard fixed duration polychemotherapy. Revista da Sociedade Brasileira de Medicina Tropical. 1995;28(3):167-8.
Type
. [Long-term effect of leprosy control in both highly endemic prefectures, Weifang of Shandong and Wenshan of Yunnan]. Zhonghua yi xue za zhi. 1995;75(6):333-7, 381-2.
Type
. Characterization of the gene encoding the immunodominant 35 kDa protein of Mycobacterium leprae. Molecular microbiology. 1995;16(5):865-76.
Type
. Antibody reactivity to mycobacterial 65 kDa heat shock protein: relevance to autoimmunity. Journal of autoimmunity. 1995;8(2):235-48.
Type
. Sustained T-cell reactivity to Mycobacterium tuberculosis specific antigens in 'split-anergic' leprosy. Leprosy review [Internet]. 1995;66(1):19-25. Available from: http://leprev.ilsl.br/pdfs/1995/v66n1/pdf/v66n1a03.pdf
Type
. Recognition of Mycobacterium leprae recombinant 18,000 MW epitopes by IgG subclasses in leprosy. Immunology. 1995;84(2):290-7.
Type
. [Dermatology topics]. Gaceta medica de Mexico. 1995;131(1):38-48.